Negative Correlation Between miR-326 and Ets-1 in Regulatory T Cells from new-Onset SLE Patients

被引:36
|
作者
Sun, Xiao-Ge [1 ]
Tao, Jin-Hui [1 ]
Xiang, Nan [1 ]
Li, Xiao-Mei [1 ]
Wang, Guo-Sheng [1 ]
Fang, Xuan [1 ]
Dai, Chao [1 ]
Zhang, Min [1 ]
Chen, Zhu [1 ]
Li, Xiang-Pei [1 ]
机构
[1] Anhui Med Univ, Anhui Prov Hosp, Dept Rheumatol & Immunol, 17 LuJiang Rd, Hefei 230001, Peoples R China
基金
中国国家自然科学基金;
关键词
systemic lupus erythematosus; regulatory T cell; microRNA-326; Ets-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHINESE HAN POPULATION; C-REACTIVE PROTEIN; PERIPHERAL-BLOOD; EXPRESSION; DIFFERENTIATION; AUTOIMMUNITY;
D O I
10.1007/s10753-016-0312-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To analyze the relationship between miR-326 and Ets-1 mRNA levels in Treg cells and clinical manifestations in patients with SLE and explore the role of miR-326 and Ets-1 in the pathogenesis and activity of SLE. Twenty-five new-onset SLE patients without treatment, twenty-eight inactive SLE patients (SLEDA a parts per thousand currency signaEuro parts per thousand 4) and twenty-two healthy controls were included in the present study. Clinical data of SLE patients were recorded. Treg cells were purified by MACS from 20 ml peripheral blood, in which the quantity of miR-326 and Ets-1 mRNA were assessed by real-time PCR. Data were analyzed using SPSS Version 17.0. The nonparametric Mann-Whitney U test was used to compare the groups, The Spearman test was used for correlation analyses. Two-tailed p values < 0.05 were considered statistically significant. 1.The level of miR-326 was significantly higher in Treg cells from SLE patients [1.98(0.592,6.148)] than that in healthy controls [0.921(0.345, 1.879)] (p = 0.032). The difference between new-onset SLE patients [6.192(0.673, 15.298)] and healthy controls was significant (p = 0.019). Significant difference of the miR-326 expression was found between new-onset SLE patients with serous cavity effusion and new-onset SLE patients without it(P < 0.05). Significant positive correlation was found between the expression of miR-326 mRNA in Treg cells with CRP and anti-C1q antibody from new-onset SLE patients. 2. The level of Ets-1 mRNA was decreased in SLE patients [0.382(0.232, 0.572)] compared to healthy controls(p = 0.013). The difference was also found in new-onset SLE patients [0.222(0.125, 0.296)] while compared to healthy controls. Also, the level in new-onset SLE patients was lower than that in inactive SLE patients [0.482(0.398, 0.512)] (p = 0.001). 3. Negative correlation was found between miR-326 and Ets-1 mRNA expression in Treg cells from new-onset SLE patients (r = -0.583 p = 0.01). 4. There was no correlation of miR-326 or Ets-1 mRNA expression with SLEDAI. The increase of miR-326 expression in Treg cells from SLE patients may inhibit the expression of Ets-1 to participate in the pathological process of SLE.
引用
收藏
页码:822 / 829
页数:8
相关论文
共 31 条
  • [11] Functional defects of regulatory T cells and the influence of age in naive and memory T cells in new-onset type 1 diabetes and first degree relatives
    Treiber, G.
    Prietl, B.
    Froehlich-Reiterer, E.
    Tauschmann, M.
    Ribitsch, A.
    Lechner, E.
    Graninger, W.
    Pieber, T. R.
    DIABETOLOGIA, 2015, 58 : S102 - S102
  • [12] A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes
    Bender, Christine
    Wiedeman, Alice E.
    Hu, Alex
    Ylescupidez, Alyssa
    Sietsema, William K.
    Herold, Kevan C.
    Griffin, Kurt J.
    Gitelman, Stephen E.
    Long, S. Alice
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (746)
  • [13] Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial
    Treiber, Genies
    Prietl, Barbara
    Froehlich-Reiterer, Elke
    Lechner, Evelyne
    Ribitsch, Anja
    Fritsch, Maria
    Rami-Merhar, Birgit
    Steigleder-Schweiger, Claudia
    Graninger, Winfried
    Borkenstein, Martin
    Pieber, Thomas R.
    CLINICAL IMMUNOLOGY, 2015, 161 (02) : 217 - 224
  • [14] Increased CD4+CD25-Foxp3+T Cells in New-onset Systemic Lupus Erythematosus Patients are Phenotypically and Functionally Different from Classic Regulatory T Cells
    Zhang, Xuan
    Zhao, Lidan
    Yang, Huaxia
    Li, Yang
    CLINICAL IMMUNOLOGY, 2010, 135 : S22 - S23
  • [15] RETRACTED: Correlation between the Variability of Glycosylated Hemoglobin and Cardiovascular Risk in New-Onset T2DM Patients (Retracted Article)
    Tong, HuoMu
    Wang, DongYing
    Fang, MiaoZhen
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [16] Reversal of new-onset type 1 diabetes in mice and induction of FoxP3+ regulatory T cells by syngeneic bone marrow transplantation
    Ouyang, Jian
    Wen, Yanting
    Chen, Junhao
    Liu, Yong
    Wu, De Pei
    BLOOD, 2007, 110 (11) : 289B - 289B
  • [17] EVALUATION OF GLUTAMATE DECARBOXYLASE (GAD65)-REACTIVE T-CELLS IN PATIENTS WITH NEW-ONSET TYPE 1 DIABETES
    Minich, Y.
    Antonevich, N.
    Hancharou, A.
    Mokhort, T.
    Mokhort, A.
    Shishko, E.
    Shyshko, V.
    DuBuske, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S55 - S55
  • [18] DEFICIENCY IN INTERLEUKIN (IL)-4 PRODUCTION BY T-CELLS FROM NEW-ONSET TYPE-I DIABETES PATIENTS
    BERMAN, MA
    WANG, Z
    SANDBORG, CI
    MFELD, KL
    ZALDIVAR, F
    BUCKINGHAM, BA
    DIABETES, 1995, 44 : A137 - A137
  • [19] 2. Durable Efficacy of Alefacept in New-Onset Type 1 Diabetes: Evidence for Lasting Modulation of Effector and Regulatory T Cells (231-OR)
    Mark R. Rigby
    Kristina M. Harris
    Ashley Pinckney
    Linda A. Dimeglio
    Marc S. Rendell
    Eric I. Felner
    Jean M. Dostou
    Stephen E. Gitelman
    Eva Tsalikian
    Kurt J. Griffin
    Peter A. Gottlieb
    Carla J. Greenbaum
    Nicole A. Sherry
    Wayne V. Moore
    Roshanak Monzavi
    Steven M. Willi
    Philip Raskin
    Lynette Keyes-Elstein
    Sarah A. Long
    Sai Kanaparthi
    Noha Lim
    Deborah Phippard
    Carol L. Soppe
    Margret L. Fitzgibbon
    James Mcnamara
    Gerald T. Nepom
    Mario R. Ehlers
    Nederlands Tijdschrift voor Diabetologie, 2015, 13 (3) : 56 - 57
  • [20] Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta
    Karimi, Leila
    Eskandari, Nahid
    Shaygannejad, Vahid
    Zare, Nasrin
    Andalib, Alireza
    Khanahmad, Hossein
    Mirmosayyeb, Omid
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2020, 19 (04) : 416 - 425